Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →
Xcellon Biologics, a Maryland CRDMO specializing in bioconjugates and complex biologics, has signed a definitive agreement to acquire the GMP biologics manufacturing facility built by NextCure, Inc. in Beltsville. The deal gives Xcellon its first cGMP capacity, completes the company’s transition from a development-stage CDMO into an end-to-end CRDMO, and puts a commissioned domestic bioconjugation […]
Read More →ATCC, a non-profit biological resource center, has been selected for three new federal contract awards using new approach methodologies (NAMs) to advance nonclinical research across infectious disease and oncology. The awards affirm ATCC’s position as a leader in new approach methodologies (NAMs) and its work to build a trusted infrastructure for nonclinical science through authenticated, […]
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly. […]
Larimar Therapeutics, a clinical-stage biotechnology company in Bala Cynwyd, Pennsylvania, focused on treatments for complex rare diseases, has appointed John Harlow as President and Chief Operating Officer, effective September 29, 2026. Harlow reports to CEO Carole Ben-Maimon, MD, and brings more than 25 years of commercial, operational, and business development experience in biopharma. “As nomlabofusp […]
Legend Biotech, a global biotechnology company based in New Jersey, has hired Josh Schwartz, MD, MBA as Senior Vice President. Legend develops advanced cell therapies across several technology platforms, including autologous and allogeneic CAR-T and natural killer (NK) cell-based immunotherapies. Schwartz will work on-site at the company’s Bridgewater, New Jersey location. Reflecting on his time […]
Aro Biotherapeutics, a Philadelphia-based clinical-stage biotechnology company developing targeted short-interfering RNA (siRNA) medicines for diseases with high unmet medical need, has appointed Brett Blackman, Ph.D., Senior Vice President, Chief Operating Officer and Chief Business Officer of Valo Health, to its Board of Directors. Blackman brings more than 25 years of experience spanning drug discovery, engineering, […]
GSK, a global biopharma company developing vaccines and specialty medicines, has hired Tyler Reynolds as Director, Digital Medicine. He joins after three years at AstraZeneca and Evinova, where he worked on digital strategy across oncology and cell therapy. In this role he’ll help shape digital strategy for the company’s respiratory, immunology and inflammation portfolio. Tyler […]
Penn Biotech Group (PBG), the cross-disciplinary, student-run graduate organization based at the Wharton School of the University of Pennsylvania, hosted Windrose Consulting Group for a recruiting session on September 10, bringing together more than 25 graduate students and postdocs from across Penn and CHOP to learn about careers in life sciences consulting. The session ran […]
Minaris, a Philadelphia, PA-based global cell and gene therapy (CGT) CDMO and multimodal biosafety testing organization, and Asimov, a Boston, MA-based company building an AI-native synthetic biology platform, announced a partnership on September 24, 2026 enabling higher-performing producer cell lines for adeno-associated virus (AAV) gene therapy manufacturing. Through OXGENE, Minaris’ center of excellence for viral […]
Suvoda, a Conshohocken, Pennsylvania-based global clinical trial technology company, announced on September 30, 2026 a new platform release marking its most significant set of advancements since unifying the Suvoda and Greenphire product lines onto a single platform following their merger. The release addresses a longstanding clinical trial challenge: study teams historically had to stitch together […]
